Literature DB >> 10917483

Treatment options for perianal Bowen's disease: survery of American Society of Colon and Rectal Surgeons Members.

R K Cleary1, J D Schaldenbrand, J J Fowler, J M Schuler, R M Lampman.   

Abstract

The aim of this study was to determine current management practices of physicians caring for patients with perianal Bowen's disease. A questionnaire was sent to 1,499 members listed in the 1997 American Society of Colon and Rectal Surgeons Directory asking them how many patients they have treated and which operative or nonoperative treatment option they choose for small (< or =3 cm), large (> 3 cm), and microscopic lesions. Of 1,499, 663 (44.2%) surgeons responded. Not all respondents answered each item. Seventy-five per cent of surgeons surveyed (n = 653) devote greater than 75 per cent of their practice to colon and rectal surgery. Of 642 respondents, 552 (86%) managed a total of <10 patients, and 90/642 (14%), > or =10 patients. Ninety-six per cent of respondents use wide local excision for patients with small lesions. Eighty-seven per cent of respondents use wide local excision for patients with large lesions. Seventy-four per cent treat patients with microscopic disease conservatively and without wide excision. The majority of surgeons caring for patients with perianal Bowen's disease are performing wide local excision for both small and large lesions. Microscopic disease was usually treated conservatively with observation alone.

Entities:  

Mesh:

Year:  2000        PMID: 10917483

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  8 in total

1.  Malignancies of the anal margin and perianal skin.

Authors:  E Dawn Wietfeldt; James Thiele
Journal:  Clin Colon Rectal Surg       Date:  2009-05

Review 2.  Anal Intraepithelial Neoplasia and Squamous Cell Cancer of the Anus.

Authors:  Rebecca E Hoedema
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

3.  Wide local excision for Buschke-Löwenstein tumor or circumferential carcinoma in situ.

Authors:  Maher A Abbas
Journal:  Tech Coloproctol       Date:  2011-07-09       Impact factor: 3.781

4.  Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women.

Authors:  Elizabeth A Stier; Stephen E Goldstone; Mark H Einstein; Naomi Jay; John M Berry; Timothy Wilkin; Jeannette Y Lee; Teresa M Darragh; Maria Da Costa; Lori Panther; David Aboulafia; Joel M Palefsky
Journal:  AIDS       Date:  2013-02-20       Impact factor: 4.177

5.  Long-term functional and quality of life outcomes of patients after repair of large perianal skin defects for Paget's and Bowen's disease.

Authors:  Alissa Conklin; Imran Hassan; Heidi K Chua; E Dawn Wietfeldt; Dirk R Larson; Kristine A Thomsen; Sanhat Nivatvongs
Journal:  J Gastrointest Surg       Date:  2009-02-18       Impact factor: 3.452

6.  Bowen's disease - a review of newer treatment options.

Authors:  Thorsten Neubert; Percy Lehmann
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

7.  Current treatment options for management of anal intraepithelial neoplasia.

Authors:  Stephen E Weis
Journal:  Onco Targets Ther       Date:  2013-06-10       Impact factor: 4.147

8.  Environmental scan of anal cancer screening practices: worldwide survey results.

Authors:  Jigisha Patel; Irving E Salit; Michael J Berry; Alexandra de Pokomandy; Mayura Nathan; Fred Fishman; Joel Palefsky; Jill Tinmouth
Journal:  Cancer Med       Date:  2014-04-16       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.